Germany – Laboratory reagents – Immunologisches Drogenscreening LVR-Kliniken
Opportunity Score
Confidence: 50%
Complexity: medium
28 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
Open tender by LVR-Kliniken for immunological drug screening tests (DxC700 AU) for clinics in Bedburg, Düsseldorf, and Viersen, performed in Cologne. 15 lots for specific substance tests (e.g., 6-Acetyl-Morphin, Amphetamine, Cannabis) plus check tests. Estimated total value only 1000 EUR, likely a unit price framework. Submission deadline 2026-07-13, German language, electronic submission required. Award based 50% price, 50% quality. Eligibility criteria referenced externally. No procurement documents analyzed beyond the TED XML notice.
Strengths
Documents available
Open procedure
Medium complexity
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Electronic submission required via the e-tendering platform (bieter.ehealth-evergabe.de).
- Tenders must be in German language.
- No variants allowed.
Award Criteria
Preis
Preis
| Criterion | Type |
|---|---|
Preis Preis | Price |
Buyer
Name
LVR-Kliniken Bedburg, Düsseldorf und Viersen
Location
Viersen, DEU
Website
Buyer profile
Identifier
73796151-bd1b-4270-b44e-ca9786d36d31
Lots (15)
Immunological drug screening for 6-Acetyl-Morphin in urine samples for LVR-Kliniken.
Immunological drug screening for Amphetamine in urine samples for LVR-Kliniken.
Immunological drug screening for Benzodiazepine in urine samples for LVR-Kliniken.
Procurement Details
Publication
10 Jun 2026
Deadline
13 Jul 2026, 09:00
Procedure
open
Contract
supplies
Language
DEU
Publication #
400917-2026
Classification
Performance: Germany
Documents (2)
Opportunity Score
Confidence: 50%
Complexity: medium
28 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation